Are you a patient? Please see the GVHD section of our site for more information. Diseases / Graft versus host disease (GVHD)
GVHD Interactive Provider Network
The goal of the Interactive GVHD Provider Network is to connect GVHD specialists with community-based providers to share expertise and discuss cases in order to improve patient care.
The network is based on the ECHO Model™ (Extension for Community Healthcare Outcomes) which uses proven adult learning techniques and interactive video technology to connect community providers with specialists at academic centers in real-time collaborative sessions.
The sessions, designed around case-based learning and mentorship, help primary care and community-based practitioners gain the expertise required to provide needed services. These sessions will also be accredited for CME credits, an added benefit for the participants.
Each one-hour virtual session will include:
- Moderator to lead the program, introduce the speakers, and manage the discussion and questions
- Case presentation(s) presented by junior faculty or community provider
- Senior level clinician to provide a didactic presentation on the session topic
- Q & A and discussion with the panel and virtual participants
Target Audience:
Physicians of all specialties, nurse practitioners, physician assistants, and other healthcare professionals who treat patients with chronic GVHD welcome to attend monthly case-based telementoring presentations and discussions.
November Session of the GVHD Provider Network
Thursday, November 17 – 7:00 am PT/8:00 am MT/9:00 am CT/10:00 am ET
Topic: Challenges of Atypical Manifestations of Chronic GVHD
Faculty:
Kirk Schultz, MD, FCAHS – Professor of Pediatrics, BC Children’s Hospital and Research Institute, University of British Columbia, Vancouver, BC
Geoffrey Cuvelier, MD, FRCPC – Director, Pediatric Blood and Marrow Transplant, Cancer Care Manitoba, Winnipeg, CA; Associate Professor, University of Manitoba, Winnipeg, CA
Iskra Pusic, MD – Associate Professor, Washington University in St. Louis
Educational Objectives:
After participating in this program the learner should be able to:
- Explain how chronic GvHD can present with atypical manifestations in organ systems not classically described by the NIH consensus criteria.
- Discuss what is known (and what is not known) about chronic GvHD involving the hematopoietic system, peripheral and central nervous system, kidneys, MSK, and serosal membranes.
- Review how to integrate the assessment of atypical chronic GVHD into patient care, including some of the limitations in doing so.
Future Monthly Session Topics:
- Chronic GVHD Supportive care: infection, lipid abnormalities, cardiovascular, chronic fatigue, psychosocial - January
Cases on these topics may be submitted to be considered for discussion during the session – please use this form to submit a case: Submission Form
-------
Target Audience
Each CE activity is intended for physicians of all specialties, nurse practitioners, physician assistants, and other healthcare professionals who treat patients with chronic GVHD.
Educational Objectives
The educational objectives are listed on the home page for each CE activity.
Physician Continuing Medical Education
This activity is certified for physicians. Please refer to applicable accreditation statements on the homepage of each CE activity.
Nursing Continuing Professional Development
This activity is certified for nurses. Please refer to applicable accreditation statements on the homepage of each CE activity.
Support Statement
Each CE activity is supported by an educational grant from Incyte Corporation.
-------
GVHD Interactive Provider Network Advisory Committee
- Steve Pavletic, MD, MS, National Cancer Institute – Chair
- Daniel Couriel, MD, MS, MBA, University of Utah
- Corey Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute
- Mary Flowers, MD, Fred Hutchinson Cancer Center
- Stephanie Lee, MD, MPH, Fred Hutchinson Cancer Center
- Kirk Schultz, MD, University of British Columbia
Accreditation, Support, and Credit
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and Aplastic Anemia and MDS International Foundation. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support Statement
This CE activity is supported by an educational grant from Incyte Corporation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 1.0 contact hour in the area of pharmacology.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Data Usage Notification
In order to support the growth of the ECHO movement, Project ECHO® collects participation data for each ECHO program. This data allows Project ECHO to measure, analyze, and report on the movement’s reach. It is used in reports, on maps and visualizations, for research, for communications and surveys, for data quality assurance activities, and for decision-making related to new initiatives. Please contact us at project.echo@hsc.utah.edu with any questions or concerns
View all previous GVHD Provider Network ECHO Programs
- Treatment Decisions in cGVHD: https://lms.mliace.org/courses/362db380-3136-11ed-a6c6-e32a95b8eccb
Faculty: Stephanie Lee, MD, MPH; Zach DeFilipp, MD; Richard Newcomb, MD - Mucocutaneous GVHD: https://lms.mliace.org/courses/dd2849d0-32c7-11ed-a999-b53e682bed77
Faculty: Mary Flowers, MD; Betty Hamilton, MD; Andrew Trunk, MD - Sclerotic GVHD: https://lms.mliace.org/public/courses/5e1ffb30-39dc-11ed-a3e0-2911566507e7
Faculty: Steven Pavletic, MD, MS; Edward Cowen, MD, MHSc; Annie Im, MD; Yazan Migdady, MD, MSc - Bronchiolitis Obliterans: https://lms.mliace.org/courses/3990a9e0-53d0-11ed-b27d-e1716396f0a1
Faculty: Corey Cutler, MD, MPH, FRCPC; Kirsten Williams, MD; Amar Kelkar, MD
Target Audience
Each CE activity is intended for physicians of all specialties, nurse practitioners, physician assistants, and other healthcare professionals who treat patients with chronic GVHD.
Educational Objectives
The educational objectives are listed on the home page for each CE activity.
Physician Continuing Medical Education
This activity is certified for physicians. Please refer to applicable accreditation statements on the homepage of each CE activity.
Nursing Continuing Professional Development
This activity is certified for nurses. Please refer to applicable accreditation statements on the homepage of each CE activity.
Support Statement
Each CE activity is supported by an educational grant from Incyte Corporation.